Viewing Study NCT00743704


Ignite Creation Date: 2025-12-17 @ 3:43 PM
Ignite Modification Date: 2025-12-23 @ 8:31 PM
Study NCT ID: NCT00743704
Status: COMPLETED
Last Update Posted: 2009-04-21
First Post: 2008-08-28
Is Possible Gene Therapy: False
Has Adverse Events: False

Brief Title: Novel Noninvasive Techniques to Study Neutrophil Airway Inflammation in an Ozone Challenge Model
Sponsor: Fraunhofer-Institute of Toxicology and Experimental Medicine
Organization:

Study Overview

Official Title: Novel Noninvasive Techniques to Study Neutrophil Airway Inflammation in an Ozone Challenge Model
Status: COMPLETED
Status Verified Date: 2009-04
Last Known Status: None
Delayed Posting: No
If Stopped, Why?: Not Stopped
Has Expanded Access: False
If Expanded Access, NCT#: N/A
Has Expanded Access, NCT# Status: N/A
Acronym: None
Brief Summary: The primary objective of this pilot study is to establish a model of neutrophil airway inflammation for future testing of anti-inflammatory substances in an early stage of clinical development. Moreover, the suitability of an electronic nose for early detection and diagnosis of airway inflammation will be determined.
Detailed Description: Experimental ozone exposure of human subjects is known to induce transient neutrophilic airway inflammation with sputum neutrophilia and elevated concentrations of inflammatory mediators in bronchoalveolar lavage and sputum supernatants. In this study, ozone at a concentration of 250 ppb will be inhaled for three hours in an ozone challenge chamber.

In a recent study, ozone challenge has been discussed as a model for pulmonary diseases dominated by neutrophilic inflammation such as COPD, providing the possibility to test new anti-inflammatory substances in early stages of clinical development.

Study Oversight

Has Oversight DMC: None
Is a FDA Regulated Drug?: None
Is a FDA Regulated Device?: None
Is an Unapproved Device?: None
Is a PPSD?: None
Is a US Export?: None
Is an FDA AA801 Violation?: